Test Price
550 AED✅ Home Collection Available
BRAF V600E Immunohistochemistry (IHC) Test in Dubai | 550 AED | DNA Labs UAE
Executive Summary & Core Metrics
Comprehensive BRAF V600E Mutation Detection via Immunohistochemistry
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for FFPE blocks and biopsy slides.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test detects the BRAF V600E oncogenic mutation through immunohistochemical staining of formalin‑fixed paraffin‑embedded (FFPE) tumor tissue, providing rapid and cost‑effective guidance for BRAF inhibitor therapy in melanomas, colorectal carcinomas, and non‑small cell lung cancers.
Methodology & Performance Comparison
| Feature | Our IHC (VE1 Antibody) | Alternative (Molecular PCR/NGS) |
|---|---|---|
| Methodology | Immunohistochemistry (FDA‑approved VE1 clone) | Real‑time PCR, Sanger Sequencing, or NGS |
| Turnaround Time | 5 days (routine FFPE block) | 7–14 days |
| Sensitivity / Concordance | >95% concordance with molecular methods | ~99% (gold standard) |
| Cost | 550 AED | 900–2,000 AED |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology, DHA Registration ID: 61713011) states: "BRAF V600E IHC serves as a highly efficient screening modality for guiding targeted therapy in solid tumors. While a positive stain provides strong initial evidence of the mutation, definitive treatment planning, particularly for BRAF inhibitor therapy, should ideally be corroborated with molecular confirmation when clinically warranted. The selection of either approach depends on tissue availability, turnaround urgency, and the specific clinical context."
Exclusion Criteria & Urgent Red Flags
- This test is not suitable for patients unable to provide a tissue biopsy or surgical specimen (blood, serum, plasma, or fluid samples are unacceptable).
- Biopsy contraindications (uncorrectable bleeding diathesis, inaccessible lesion) must be assessed by the treating physician.
- Emergency Red Flags: Seek immediate medical care if you develop fever, purulent drainage, or uncontrolled pain at the biopsy site after the procedure.
- Pregnant or breastfeeding women should discuss biopsy risks with their obstetrician before scheduling the test.
Patient FAQ & Clinical Guidance
1. What does a positive BRAF V600E IHC result indicate?
A positive result indicates the presence of the V600E mutant protein, often linked to melanoma, colorectal or non‑small cell lung cancer. This finding may qualify you for targeted therapies like BRAF inhibitors. Clinical correlation with imaging and pathology reports is mandatory before any treatment change.
2. How should I prepare for the BRAF V600E IHC test?
No fasting or special preparation is required. The test is performed on tissue already obtained through a biopsy or surgical excision. Your oncologist or surgeon will arrange the procedure. Please provide a copy of the histopathology report, biopsy site, and complete clinical history.
3. Is the BRAF V600E IHC test covered by UAE health insurance?
Most UAE insurance plans cover this test when ordered by an Oncologist or Surgical Pathologist for targeted therapy guidance. We offer direct billing verification via WhatsApp at +971 54 548 8731 before sample collection. Coverage may require pre‑authorization, so we assist with the process.
UAE Regulatory & Data Privacy Adherence
Your Data, Securely Managed
DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data, including test results and clinical details, are encrypted and handled with the highest confidentiality. Our DHA-licensed facility (Licence No. 1143) located in Dubai Healthcare City ensures full compliance with local and international medical data governance standards.
Clinical & Logistical Metadata
| Test Name | BRAF V600E Immunohistochemistry (IHC) |
| Price (AED) | 550 AED |
| Turnaround Time | 5 working days (FFPE block) |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Block or Biopsy Slides |
| Methodology Used | Immunohistochemistry (Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody) |
| ICD-10-CM Code | C80.1 (Malignant neoplasm, primary site unknown, so stated), Z85.9 (Personal history of malignant neoplasm, unspecified) |
| LOINC Code | 95163-7 (BRAF V600E protein [Interpretation] in Tissue by Immune stain) |
| DHA Facility License & Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians